PODCAST

Suzanne calls up Karen Sepucha, PhD, director of the Health Decision Sciences Center in the General Medicine Division at Massachusetts General Hospital and an associate professor in Medicine at Harvard Medical School to discuss shared decision making.

So what do the data say? Well, they confirm a lot of what employer-purchasers are feeling at the moment.

“We’re seeing just about the fastest rate of health care inflation in our data ever.”

What’s a solution? Price Transparency Data.

We have all of this price transparency data, what are we going to do with it?

Well, we need a new model if we’re going to get consumers to use it. We have to get to them upstream, we have to make it really simple, and we have to change the incentives so that they save thousands of dollars by getting with the program.

Suzanne calls up Nick Reber, CEO and Founder of Garner Health to talk price transparency, analytics, and quality.

So what do the data say? Well, they confirm a lot of what employer-purchasers are feeling at the moment.

“We’re seeing just about the fastest rate of health care inflation in our data ever.”

What’s a solution? Price Transparency Data.

We have all of this price transparency data, what are we going to do with it?

Well, we need a new model if we’re going to get consumers to use it. We have to get to them upstream, we have to make it really simple, and we have to change the incentives so that they save thousands of dollars by getting with the program.

Suzanne calls up Aneesh Chopra, Co-Founder and President of CareJourney, to talk about the current state of health care transparency policy and how the US is faring. So, what’s the mood on current regulations and government oversight? “The general feeling in the field is one of skepticism,” says Chopra, but he’s much more bullish on it. According to Chopra, based on research CareJourney conducted in partnership with Turquoise Health, “two-thirds of hospitals as of the spring of 2022…actually have meaningful, high-quality transparency data.” The question now is are we going to see this information put to use?

Suzanne calls Alice Hm Chen, Chief Medical Officer at Covered California, and asks about her work in quality measurement and health equity.

As the nation’s largest state-based health insurance exchange, how is Covered California thinking about its responsibility to deliver equitable care to its member population?

“I think a key thing for everyone to embrace is, equity is quality…you won’t get to true high-quality care unless you are addressing equity.”

Suzanne Delbanco speaks with Roslyn (Roz) Murray, a doctoral candidate at The University of Michigan School of Public Health and former Catalyst for Payment Reform employee.

Roz delves into her first peer-reviewed paper in Health Affairs, which concludes that the evidence on commercial value-based payment models is mixed. This is the first systemic review of the quality, spending, and utilization effects of commercial models, extracting results from fifty-nine studies.

Suzanne and Roz dive into why there is such little research in the commercial sector on value-based payment and compare Roz’s findings to research done in the public sector.